Xie Jiao, Li Ling, Zhao Lei
Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P.R. China.
Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022,China.
Mini Rev Med Chem. 2021;21(19):3030-3036. doi: 10.2174/1389557521666210405160658.
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Its pathogenesis is closely related to insulin resistance, obesity, type 2 diabetes, and hyperlipidemia. Due to the complex pathogenesis, there are no specific medications for treating NAFLD. The most effective way to treat NAFLD is to lose weight through diet intervention and exercise, but a large number of in vitro and in vivo experiments have confirmed that a variety of natural drugs can interfere with NAFLD through many mechanisms, and the curative effect is remarkable. This paper reviews the action mechanism of crude extracts of medicinal plants (Polygonum multiflorum, Artemisia annua leaves, and Artemisia annua leaves) and natural products such as berberine (BBR), curcumin, betulinic acid (BA), ginsenoside Rg1 (G-rg1), and silybin on NAFLD, which aims to provide useful information for further research and development of new drugs to improve the cure rate of non-alcoholic fatty liver.
非酒精性脂肪性肝病(NAFLD)是全球最常见的慢性肝病。其发病机制与胰岛素抵抗、肥胖、2型糖尿病和高脂血症密切相关。由于发病机制复杂,目前尚无治疗NAFLD的特效药物。治疗NAFLD最有效的方法是通过饮食干预和运动来减轻体重,但大量的体外和体内实验证实,多种天然药物可通过多种机制干预NAFLD,且疗效显著。本文综述了药用植物(何首乌、青蒿叶)粗提物以及小檗碱(BBR)、姜黄素、桦木酸(BA)、人参皂苷Rg1(G-rg1)和水飞蓟宾等天然产物对NAFLD的作用机制,旨在为进一步研发提高非酒精性脂肪肝治愈率的新药提供有用信息。